Stock Earnings

Question 1

What are Alaunos Therapeutics Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Alaunos Therapeutics Inc has a total asset of $2, Net loss of $-4

Question 2

What are the key financial ratios for TCRT?

Accepted Answer

Alaunos Therapeutics Inc's Current ratio is 0, has a Net margin is 0, sales per share of $0.

Question 3

How is Alaunos Therapeutics Inc's revenue broken down by segment or geography?

Accepted Answer

Alaunos Therapeutics Inc largest revenue segment is T-cell Therapies, at a revenue of 5,000 in the most earnings release.For geography, United States is the primary market for Alaunos Therapeutics Inc, at a revenue of 5,000.

Question 4

Is Alaunos Therapeutics Inc profitable?

Accepted Answer

no, according to the latest financial statements, Alaunos Therapeutics Inc has a net loss of $-4

Question 5

Does Alaunos Therapeutics Inc have any liabilities?

Accepted Answer

no, Alaunos Therapeutics Inc has liability of 0

Question 6

How many outstanding shares for Alaunos Therapeutics Inc?

Accepted Answer

Alaunos Therapeutics Inc has a total outstanding shares of 1.6

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	0	0	0	2	0	0
Revenue Growth (YoY)	--	--	-100%	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	3	4	12	13	26	27
Research & Development	1	0	16	25	47	52
Operating Expenses	4	4	28	38	73	80
Other Non Operating Income (Expenses)	0	0	1	0	0	0
Pretax Income	-4	-4	-35	-37	-78	-79
Income Tax Expense	--	--	--	--	--	--
Net Income	-4	-4	-35	-37	-78	-79
Net Income Growth	-64%	-89%	-5%	-53%	-1%	-32%
Shares Outstanding (Diluted)	2.18	1.6	15.99	14.47	14.29	13.97
Shares Change (YoY)	36%	-90%	10%	1%	2%	25%
EPS (Diluted)	-1.84	-2.92	-2.2	-2.61	-5.51	-5.72
EPS Growth	-75%	33%	-16%	-53%	-4%	-46%
Free Cash Flow	-3	-4	-30	-29	-64	-66
Free Cash Flow Per Share	-1.37	-2.49	-1.87	-2	-4.47	-4.72
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	0%	-1,750%	0%	0%
Profit Margin	0%	0%	0%	-1,850%	0%	0%
Free Cash Flow Margin	0%	0%	0%	-1,450%	0%	0%
EBITDA	-4	-4	-26	-33	-71	-79
EBITDA Margin	0%	0%	0%	-1,650%	0%	0%
D&A For EBITDA	0	0	2	2	2	1
EBIT	-4	-4	-28	-35	-73	-80
EBIT Margin	0%	0%	0%	-1,750%	0%	0%
Effective Tax Rate	--	--	--	--	--	--

Alaunos Therapeutics Inc (TCRT) Price

TCRT Stock Price Chart

TCRT Income

Follow-Up Questions